bf/NASDAQ:RZLT_icon.jpeg

COM:REZOLUTEBIO

Rezolute, Inc.

  • Stock

Last Close

5.01

21/11 21:00

Market Cap

220.96M

Beta: -

Volume Today

282.98K

Avg: -

Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder...Show More

peer of

competitor of